| Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease EM Rocha, B De Miranda, LH Sanders Neurobiology of disease 109, 249-257, 2018 | 681 | 2018 |
| LRRK2 activation in idiopathic Parkinson’s disease R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... Science translational medicine 10 (451), eaar5429, 2018 | 448 | 2018 |
| Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease BR De Miranda, EM Rocha, Q Bai, A El Ayadi, D Hinkle, EA Burton, ... Neurobiology of disease 115, 101-114, 2018 | 100 | 2018 |
| The Nurr1 activator 1, 1-bis (3′-indolyl)-1-(p-chlorophenyl) methane blocks inflammatory gene expression in BV-2 microglial cells by inhibiting nuclear factor κB BR De Miranda, KA Popichak, SL Hammond, BA Jorgensen, AT Phillips, ... Molecular pharmacology 87 (6), 1021-1034, 2015 | 86 | 2015 |
| LRRK2 and idiopathic Parkinson’s disease EM Rocha, MT Keeney, R Di Maio, BR De Miranda, JT Greenamyre Trends in neurosciences 45 (3), 224-236, 2022 | 78 | 2022 |
| Preventing Parkinson’s disease: an environmental agenda BR De Miranda, SM Goldman, GW Miller, JT Greenamyre, E Dorsey Journal of Parkinson's disease 12 (1), 45-68, 2022 | 77 | 2022 |
| LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease EM Rocha, BR De Miranda, S Castro, R Drolet, NG Hatcher, L Yao, ... Neurobiology of disease 134, 104626, 2020 | 77 | 2020 |
| Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson’s disease BR De Miranda, JA Miller, RJ Hansen, PJ Lunghofer, S Safe, ... Journal of Pharmacology and Experimental Therapeutics 345 (1), 125-138, 2013 | 70 | 2013 |
| Novel Para-Phenyl Substituted Diindolylmethanes Protect Against MPTP Neurotoxicity and Suppress Glial Activation in a Mouse Model of Parkinson’s Disease BR De Miranda, KA Popichak, SL Hammond, JA Miller, S Safe, ... Toxicological Sciences 143 (2), 360-373, 2015 | 59 | 2015 |
| Sex differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson’s disease incidence BR De Miranda, M Fazzari, EM Rocha, S Castro, JT Greenamyre Toxicological sciences 170 (1), 133-143, 2019 | 52 | 2019 |
| Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease BR De Miranda, JT Greenamyreabc Environmental Science: Processes & Impacts, 2020 | 49 | 2020 |
| Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration A Zharikov, Q Bai, BR De Miranda, A Van Laar, JT Greenamyre, ... Neurobiology of disease 125, 146-153, 2019 | 44 | 2019 |
| The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease BR De Miranda, SL Castro, EM Rocha, CR Bodle, KE Johnson, ... Neurobiology of disease 153, 105312, 2021 | 41 | 2021 |
| Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20 BR De Miranda, EM Rocha, SL Castro, JT Greenamyre npj Parkinson's Disease 6 (1), 38, 2020 | 33 | 2020 |
| Vesicular glutamate transporter modulates sex differences in dopamine neuron vulnerability to age‐related neurodegeneration SA Buck, T Steinkellner, D Aslanoglou, M Villeneuve, SH Bhatte, ... Aging cell 20 (5), e13365, 2021 | 29 | 2021 |
| Low‐dose 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor‐κB reporter mice prior to loss of dopaminergic neurons JA Miller, BR Trout, KA Sullivan, RA Bialecki, RA Roberts, RB Tjalkens Journal of neuroscience research 89 (3), 406-417, 2011 | 26 | 2011 |
| VGLUT2 is a determinant of dopamine neuron resilience in a rotenone model of dopamine neurodegeneration SA Buck, BR De Miranda, RW Logan, KN Fish, JT Greenamyre, ... Journal of Neuroscience 41 (22), 4937-4947, 2021 | 24 | 2021 |
| Trichloroethylene: An invisible cause of Parkinson’s disease? E Dorsey, M Zafar, SE Lettenberger, ME Pawlik, D Kinel, M Frissen, ... Journal of Parkinson's disease 13 (2), 203-218, 2023 | 22 | 2023 |
| LRRK2 activation in idiopathic Parkinson’s disease. Sci Transl Med 10: eaar5429 R Di Maio, EK Hoffman, EM Rocha, MT Keeney, LH Sanders, ... | 19 | 2018 |
| Etiology and pathogenesis of Parkinson’s disease BR de Miranda, JT Greenamyre | 15 | 2017 |
